Stepping up from opt-out: Achieving 100% uptake antenatal human immunodeficiency virus testing

Abstract

All pregnant women in the United Kingdom are offered and encouraged to take up screening for human immunodeficiency virus (HIV), hepatitis B and syphilis, with excellent uptake rates and engagement in care resulting in very few infants being infected with HIV in the United Kingdom. However, in that small number of women who decline testing, there remains an opportunity to offer further support to test and engage them and their baby in care, even if this happens in labour or immediately after birth. In addition, these women may be at increased risk of HIV. Our hospital is in an extremely high prevalence area for HIV, and most untested individuals are of childbearing age. We embarked on a quality improvement project to engage all women delivering at our unit in HIV testing or to test their babies via cord blood at birth. We sought to do this in a constructive and inclusive way, led by the HIV specialist midwife with the support of the HIV antenatal and the hospital senior management teams. Following an initial evaluation, the approach was modified and an innovative approach together with a trusted advocate was used to engage a particularly hard-to-reach group. We have achieved 100% uptake of HIV testing and made two HIV diagnoses that would not otherwise have been made; both in women who reported themselves not to be at risk and both engaged in care and delivered HIV-negative infants.

Keywords

Screening human immunodeficiency virus

Get full access to this article

View all access options for this article.

References

https://www.gov.uk/government/publications/infectious-diseases-in-pregnancy-screening-programme-standards (accessed 17 March 2021).

Public Health England . Screening KPI data summary factsheets: August 2018 issue 4. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/732590/Screening_KPI_SummaryFactsheets_August2018_Issue4.pdf (2018, accessed 27 March 2021).

Boxall

Smith

. Antenatal screening for HIV; are those who refuse testing at higher risk than those who accept testing? J Public Health 2004; 26(3): 285–287.

NSHPC, UCL Great Ormond Street Institute of Child Health . Obstetric and paediatric HIV surveillance data from the UK and Ireland: January 2019 update. Available at: https://www.ucl.ac.uk/nshpc/sites/nshpc/files/nshpc_slides_jan_2019_0.pdf (2019, accessed 17 March 2021).

British HIV Association . British HIV Association guidelines for the management of HIV infection in pregnant women 2018, BHIVA, 2018.

Peters

Thorne

Tookey

, et al.

National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt?

HIV Med 2018; 19(4): 280–289.

Public Health England . Annual epidemiological spotlight on HIV in North West 2017 data, 2017PHE publications. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/786650/HIV_Spotlight_north-west_2017_data.pdf (accessed 17 March 2021).

Astill

Miall

Shillito

, et al. Managing women who decline HIV testing in pregnancy and their infants? a multidisciplinary team guideline. HIV Med 2019; 20(9): 601–605.

Public Health England . Antenatal and newborn screening KPIs for 2018 to 2019: definitions, Available at: https://www.gov.uk/government/publications/nhs-population-screening-reporting-data-definitions/antenatal-and-newborn-screening-kpis-for-2018-to-2019definitions (2018, accessed 15 May 2019).